Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba castellanii

Graefes Arch Clin Exp Ophthalmol. 2013 Feb;251(2):509-14. doi: 10.1007/s00417-012-2176-4. Epub 2012 Oct 19.

Abstract

Purpose: To investigate whether ultraviolet light (UVA) at 365 nm can inhibit/eliminate Acanthamoeba growth and if riboflavin would potentiate such an association.

Methods: Acanthamoeba castellanii in a fluid medium with a concentration of approximately 1.7 × 10(4) protozoa/ml were prepared with (0.01 %) and without riboflavin. Exposure of UVA (dose 5.475 J/cm(2)) took place twice, with each illumination period followed by culturing of 10 μl in peptone yeast-extract glucose (PYG) medium for 7 days. Every suspension prepared had a non-exposed control solution. Determination of Acanthamoeba was conducted daily, by count in Burker chamber days 4 through 7 after exposure. Statistical analysis was done by repeated-measurement ANOVA and post-hoc analysis for unpaired samples.

Results: The exposure of ultraviolet light resulted in an inhibited growth of Acanthamoeba compared to the non-exposed solutions, with a statistically significant reduction over time (p = 0.0003). The addition of riboflavin did not amplify the effect, and there were no tendencies for an interaction effect between UVA and riboflavin.

Conclusions: The antiprotozoal effect of the UVA wavelength, utilized in CXL, is solely mediated by ultraviolet light, and riboflavin does not seem to amplify the antimicrobial efficacy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acanthamoeba castellanii / drug effects*
  • Acanthamoeba castellanii / growth & development
  • Acanthamoeba castellanii / radiation effects*
  • Parasitic Sensitivity Tests
  • Photosensitizing Agents / pharmacology*
  • Riboflavin / pharmacology*
  • Ultraviolet Rays*

Substances

  • Photosensitizing Agents
  • Riboflavin